| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Eris Lifesciences Limited (NSE: ERIS)
ERIS Technical Analysis
4
| As on 30th Apr 2024 ERIS SHARE Price closed @ 895.95 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 831.54 & Buy for SHORT-TERM with Stoploss of 869.44 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ERISSHARE Price
| Open | 895.45 | Change | Price | % |
| High | 899.40 | 1 Day | 2.45 | 0.27 |
| Low | 882.35 | 1 Week | 12.95 | 1.47 |
| Close | 895.95 | 1 Month | 52.60 | 6.24 |
| Volume | 535447 | 1 Year | 264.70 | 41.93 |
| 52 Week High 846.25 | 52 Week Low 567.95 | ||||
NSE INDIA Most Active Stocks
| IDEA | 13.20 | -1.86% |
| YESBANK | 26.15 | -3.51% |
| NHPC | 96.20 | 3.00% |
| PNB | 141.05 | 2.77% |
| IDFCFIRSTB | 82.15 | 0.61% |
| RECLTD | 507.15 | 9.54% |
| IOC | 168.85 | -4.47% |
| MAHABANK | 70.10 | -1.34% |
| HFCL | 100.50 | 2.60% |
| TATASTEEL | 165.00 | -1.43% |
NSE INDIA Top Gainers Stocks
| HISARMETAL | 222.00 | 20.00% |
| WILLAMAGOR | 40.95 | 19.91% |
| NGIL | 61.65 | 15.67% |
| LIKHITHA | 351.20 | 12.80% |
| COMPUSOFT | 36.45 | 11.98% |
| PDMJEPAPER | 83.50 | 11.71% |
| BFUTILITIE | 862.25 | 10.74% |
| POWERINDIA | 9578.75 | 10.53% |
| IRIS | 155.15 | 10.00% |
| HINDMOTORS | 34.65 | 10.00% |
NSE INDIA Top Losers Stocks
| ERIS Daily Charts |
ERIS Intraday Charts |
Whats New @ Bazaartrend |
ERIS Free Analysis |
|
|
ERIS Important Levels Intraday
| RESISTANCE | 928.81 |
| RESISTANCE | 918.27 |
| RESISTANCE | 911.76 |
| RESISTANCE | 905.24 |
| SUPPORT | 886.66 |
| SUPPORT | 880.14 |
| SUPPORT | 873.63 |
| SUPPORT | 863.09 |
ERIS Target May 2024
| 4th UP Target | 1110.64 |
| 3rd UP Target | 1038.61 |
| 2nd UP Target | 994.09 |
| 1st UP Target | 949.57 |
| 1st DOWN Target | 822.53 |
| 2nd DOWN Target | 778.01 |
| 3rd DOWN Target | 733.49 |
| 4th DOWN Target | 661.46 |
ERIS Weekly Target
| 4th UP Target | 974.46 |
| 3rd UP Target | 948.32 |
| 2nd UP Target | 932.16 |
| 1st UP Target | 916.00 |
| 1st DOWN Target | 869.90 |
| 2nd DOWN Target | 853.74 |
| 3rd DOWN Target | 837.58 |
| 4th DOWN Target | 811.44 |
ERIS Target2024
| 4th UP Target | 1720.5 |
| 3rd UP Target | 1460.57 |
| 2nd UP Target | 1299.9 |
| 1st UP Target | 1139.23 |
| 1st DOWN Target | 680.77 |
| 2nd DOWN Target | 520.1 |
| 3rd DOWN Target | 359.43 |
| 4th DOWN Target | 99.5 |
Eris Lifesciences Limited ( NSE INDIA Symbol : ERIS )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ERIS Synopsis Technicals View
| 50 Day EMA |
Close is Above EMA 50 (Short Term) |
Bullish | |
| 100 Day EMA | Close is Above EMA 100 (Mid Term) | Bullish | |
| 200 Day EMA | Close is Above EMA 200 (Long Term) | Bullish | |
| MACD (12 26 9) | MACD Line is Less Then SIGNAL Line | Bearish | |
| RSI (14) | RSI is Below 30 | Over Sold | |
| MFI (14) | MFI is 22.44 | Sideways | |
| CCI (20) | CCI is Below -100 | Over Sold | |
| WILLIAM %R (14) | William %R is -47.38 | Sideways | |
| ADX (14) | ADX is Above 20 & +DI is Below -DI | Down Trend | |
| PSAR | Stoploss For Long Buy | 321.00 | |
| 10 Day Avg Volume | Traded 456.30 % More then 10 Day Average Volume | ||
ERIS Other Details
| Segment | EQ | |
| Market Capital | 110092763136.00 | |
| Sector | Healthcare | |
| Industry | Drug Manufacturers-Specialty & Generic | |
| Offical website | > | |
ERIS Address
 |
||
ERIS Latest News
ERIS Business Profile
Eris Lifesciences Limited manufactures, markets, and distributes pharmaceutical products in India. It offers various branded formulations in various therapeutic areas, such as cardiovascular, anti?diabetes, anti-infective, antipyretics, vitamins/nutrients, gastroenterology, acute and chronic respiratory, gynecology, pediatrics, neurology, psychiatry, arthritis, and pain/analgesics, as well as in-vitro fertilization, cancer, multi-therapy, cosmetology, and dermatology. The company has an in-licensing partnership with Microlife to offer a range of medical devices comprising blood pressure monitors, blood glucose monitors, infra-red thermometers, nebulizers, and pregnancy testing kits under the CIRCA brand. Eris Lifesciences Limited was incorporated in 2007 and is based in Ahmedabad, India. Address: Commerce House IV, Ahmedabad, India, 380015
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service